Intuitive Surgical Free Cash Flow 2010-2024 | ISRG

Intuitive Surgical annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
  • Intuitive Surgical free cash flow for the quarter ending September 30, 2024 was 793.20, a year-over-year.
  • Intuitive Surgical free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.
  • Intuitive Surgical annual free cash flow for 2023 was $0.75B, a 21.79% decline from 2022.
  • Intuitive Surgical annual free cash flow for 2022 was $0.958B, a 45.23% decline from 2021.
  • Intuitive Surgical annual free cash flow for 2021 was $1.75B, a 53.06% increase from 2020.
Intuitive Surgical Annual Free Cash Flow
2023 749.60
2022 958.40
2021 1,749.90
2020 1,143.30
2019 1,172.60
2018 982.20
2017 953.20
2016 1,033.10
2015 725.20
2014 559.50
2013 775.40
2012 700.00
2011 594.70
2010 449.80
2009 338.80
Intuitive Surgical Quarterly Free Cash Flow
2024-09-30 793.20
2024-06-30 334.60
2024-03-31 23.50
2023-12-31 749.60
2023-09-30 956.80
2023-06-30 664.70
2023-03-31 177.30
2022-12-31 958.40
2022-09-30 659.70
2022-06-30 445.60
2022-03-31 129.40
2021-12-31 1,749.90
2021-09-30 1,319.10
2021-06-30 886.00
2021-03-31 419.00
2020-12-31 1,143.30
2020-09-30 577.70
2020-06-30 367.50
2020-03-31 247.60
2019-12-31 1,172.60
2019-09-30 761.90
2019-06-30 452.30
2019-03-31 218.40
2018-12-31 982.20
2018-09-30 699.60
2018-06-30 426.80
2018-03-31 240.10
2017-12-31 953.20
2017-09-30 652.20
2017-06-30 349.70
2017-03-31 188.50
2016-12-31 1,033.10
2016-09-30 721.20
2016-06-30 467.50
2016-03-31 217.20
2015-12-31 725.20
2015-09-30 427.20
2015-06-30 276.00
2015-03-31 104.50
2014-12-31 559.50
2014-09-30 430.50
2014-06-30 293.70
2014-03-31 158.20
2013-12-31 775.40
2013-09-30 575.20
2013-06-30 405.40
2013-03-31 241.30
2012-12-31 700.00
2012-09-30 543.90
2012-06-30 319.40
2012-03-31 116.70
2011-12-31 594.70
2011-09-30 396.20
2011-06-30 253.10
2011-03-31 90.70
2010-12-31 449.80
2010-09-30 317.50
2010-06-30 254.60
2010-03-31 99.40
2009-12-31 338.80
2009-09-30 223.70
2009-06-30 132.80
2009-03-31 62.60
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $191.293B $7.124B
Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $206.837B 25.23
Alcon (ALC) Switzerland $42.858B 28.68
Edwards Lifesciences (EW) United States $38.815B 24.65
IQVIA Holdings (IQV) United States $38.763B 21.36
IDEXX Laboratories (IDXX) United States $34.892B 41.09
DexCom (DXCM) United States $29.037B 43.73
Waters (WAT) United States $22.907B 33.87
STERIS (STE) Ireland $21.985B 25.31
SONOVA HOLDING (SONVY) Switzerland $21.643B 0.00
Hologic (HOLX) United States $18.526B 19.55
Sysmex ADR (SSMXY) Japan $12.594B 39.49
Fresenius Medical Care AG KGaA (FMS) Germany $12.447B 12.78
Globus Medical (GMED) United States $11.296B 28.77
Teleflex (TFX) United States $9.083B 14.49
Penumbra (PEN) United States $9.066B 88.81
Masimo (MASI) United States $8.612B 41.67
Glaukos (GKOS) United States $7.919B 0.00
PROCEPT BioRobotics (PRCT) United States $4.986B 0.00
Integer Holdings (ITGR) United States $4.592B 26.02
TransMedics (TMDX) United States $3.068B 97.25
Inari Medical (NARI) United States $3.003B 0.00
Veracyte (VCYT) United States $2.964B 88.93
LivaNova (LIVN) United Kingdom $2.878B 16.61
Nihon Kohden (NHNKY) Japan $2.557B 19.42
Elekta AB (EKTAY) Sweden $2.252B 18.35
Tandem Diabetes Care (TNDM) United States $2.043B 0.00
Integra LifeSciences Holdings (IART) United States $1.914B 10.00
RxSight (RXST) United States $1.832B 0.00
Alphatec Holdings (ATEC) United States $1.316B 0.00
Artivion (AORT) United States $1.162B 77.03
OPKO Health (OPK) United States $1.099B 0.00
Pulse Biosciences (PLSE) United States $1.091B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.915B 15.55
ORTHOFIX MEDICAL INC (OFIX) United States $0.735B 0.00
IRadimed (IRMD) United States $0.722B 39.01
SiBone (SIBN) United States $0.652B 0.00
Paragon 28 (FNA) United States $0.627B 0.00
Mesa Laboratories (MLAB) United States $0.610B 14.39
Pacific Biosciences Of California (PACB) United States $0.601B 0.00
AxoGen (AXGN) United States $0.584B 0.00
OrthoPediatrics (KIDS) United States $0.582B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.383B 0.00
Semler Scientific (SMLR) United States $0.383B 25.71
Tactile Systems Technology (TCMD) United States $0.378B 20.45
Delcath Systems (DCTH) United States $0.310B 0.00
ClearPoint Neuro (CLPT) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.249B 0.00
Sight Sciences (SGHT) United States $0.215B 0.00
NeuroPace (NPCE) United States $0.208B 0.00
Accuray (ARAY) United States $0.192B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
Sensus Healthcare (SRTS) United States $0.117B 17.44
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
908 Devices (MASS) United States $0.101B 0.00
EDAP TMS S.A (EDAP) France $0.098B 0.00
LENSAR (LNSR) United States $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
WORK Medical Technology Group (WOK) China $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.068B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.061B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Lucid Diagnostics (LUCD) United States $0.054B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Accelerate Diagnostics (AXDX) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Adagio Medical Holdings (ADGM) United States $0.032B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
Neuronetics (STIM) United States $0.021B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00